Skip to content

MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla

Positive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence, One Hour After Intravenous Gadolinium Injection, on a 1.5 Tesla

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03452410
Enrollment
35
Registered
2018-03-02
Start date
2018-02-23
Completion date
2019-02-23
Last updated
2019-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Neuritis

Keywords

Vestibular neuritis, Magnetic resonance imaging (MRI), Vertigo, Fluid attenuated inversion recuperation (FLAIR)

Brief summary

Our objective is to allow positive MRI diagnosis of vestibular neuritis by highlighting contrast enhancement of the vestibular nerve on the pathological side of the FLAIR sequence acquired 1h after intravenous gadolinium injection in patients with typical vestibular neuritis. At present, the diagnosis is based on a combination clinical examination / video-head impulse test, and no imaging examination allows the diagnosis to be positive.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* Age 18-80 years * Presence of a typical unilateral vestibular neuritis during the ENT examination with videonystagmography * Subject having his agreement for the use of his medical data for research purposes.

Exclusion criteria

* Special clinical forms of the disease: doubtful or atypical forms, especially the presence of deafness * Treatments and related interfering diseases, antecedents: antecedents of neuritis for controls, presence of vertigo, bilateral involvement * Impossibility to give the subject information enlightened (subject in emergency situation, difficulties of understanding the subject, ...) * Subject under the protection of justice * Subject under guardianship or curatorship

Design outcomes

Primary

MeasureTime frame
Diagnosis of vestibular neuritisone hour after intravenous gadolinium injection

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026